Santhera partners with Clinigen to supply Agamree for Duchenne muscular dystrophy in regions without commercial availability.

China’s National Medical Products Administration (NMPA) has approved the second New Drug Application (NDA) of Dovbleron ...

Californian biotech General Proximity announced its emergence from stealth on Friday, unveiling its proprietary OmniTAC ...

"A dynamic and versatile pharmaceutical company with regional horizons in Latin America." "Axon Pharma is an independent multinational pharmaceutical company built on high-standards science and ...